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Supplementary Figure 1. Directed acyclic graph showing the framework of this study, in 
which alcohol flushing (a proxy for genetic variation in aldehyde dehydrogenase 2 [ALDH2]) 
was used as an instrumental variable. 
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Supplementary Figure 2. Flow diagram of how the study subjects were identified. 
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Supplementary Table 1. Relationship of age with alcohol flushing status and alcohol consumption. 
Variables Age (years) 
 Men        Women       
 Overall  <30 30–39 40–49 50–59 ≥60  P-value  Overall <30 30–39 40–49 50–59 ≥60  P-value 
Number  20 696 94 8244 9847 2161 350   3985 201 1539 1847 318 80  
Alcohol flushers  28.7  32.9 29.0 27.9 29.8 34.2 0.030  28.4  31.3  29.5  29.0  25.5  27.5  0.603  
Alcohol 
consumption 
               
 0 g/day 7.6  4.3  9.6  6.3  5.6  10.9  <0.001  22.8  4.5  28.3  19.6  23.3  36.3  <0.001 
<8 g/day 39.5  37.2  42.9  37.7  34.5  42.3    66.1  72.1  59.3  71.5  65.1  58.8   
8–30 g/day 37.0  39.4  35.0  38.4  39.2  31.1    9.4  17.9  10.7  7.4  10.1  5.0   
≥30 g/day 15.9  19.2  12.5  17.6  20.7  15.7    1.8  5.5  1.7  1.5  1.6  0.0   
Unless otherwise indicated, data are presented as percentages. 
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Supplementary Table 2. Relationships between alcohol consumption and covariates among men and women. 
  Men  Women 






≥30 g/day  
(n=3280) 






≥30 g/day  
(n=70) 
P-value  
Age (years)a 39.6 (7.1) 40.3(7.0) 41.0 (6.8) 42.0 (7.0) <0.001  39.9 (7.5) 40.1 (7.4) 38.3 (7.9) 38.9 (9.4) <0.001 
Educationb                 
Elementary or less 0.3  0.2  0.2  0.2  <0.001  3.0  1.1  2.4  2.9  <0.001 
Middle or high school  8.6  8.9  11.5  19.4     17.0  25.9  33.8  51.4    
College or over 91.1  90.9  88.3  80.4     80.0  73.0  63.8  45.7    
Monthly household incomeb         <0.001          <0.001 
<4,000 USD 22.9  20.4  19.6  20.1     21.8  19.9  24.7  35.7    
4,000–5,999 USD 31.9  33.8  33.5  30.9     30.2  27.4  27.4  24.3    
≥6,000 USD 32.3  31.9  35.0  35.6     30.7  31.5  29.2  22.9    
Unknown 13.0  14.0  11.9  13.4     17.4  21.1  18.8  17.1    
Cigarette smoking 
(cigarettes/day)b 
        <0.001          <0.001 
Non-smoker  46.1  42.4  25.6  16.7     96.2  95.3  83.9  77.1    
Ex-smoker 28.8  31.3  34.7  34.3     2.0  2.6  8.6  8.6    
Current smoker (<10) 24.7  26.1  39.3  48.7     2.0 2.1  7.2  14.3    
Current smoker (≥10) 0.2 0.2 0.4 0.3   0.2 0.1 0.3 0.0  
Physical activityb         <0.001          0.010  
Inactive 41.9  43.9  46.2  48.6     50.7  52.4  58.5  55.7    
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Minimally active 50.8  49.3  46.5  42.7     42.0  39.4  32.7  28.6    
HEPA 7.4  6.8  7.3  8.8     7.4  8.2  8.9  15.7    
Adult height (cm)a 173.2 (5.8) 173.0 (5.6) 173.3 (5.6) 173.4 (5.5) <0.001  160.4 (5.2) 160.4 (5.2) 160.7 (5.2) 161.3 (4.5) 0.290  
Anti-diabetic 
medicationsb 
2.9  2.6  2.8  4.3  <0.001  2.2  1.0  0.5  1.4  0.015 
Anti-hypertensive 
medicationsb 
7.3  6.7  8.6  11.5  <0.001  4.7  3.6  2.7  5.7  0.212  
Anti-dyslipidemic 
medicationsb  
4.6  4.2  4.4  5.1  0.160  2.4  2.5  1.3  1.4  0.530  
Alcohol flushersb 50.8  41.9  18.4  9.2  <0.001  36.9  29.2  11.5  10.0  <0.001 
Data are presented as ameans (standard deviation), or bpercentages.  






Supplementary Table 3. Unadjusted associations of alcohol flushing status with cardiovascular risk factors and coronary artery calcium 
scores in men and women. 
Variables  Men  Women 









  (n=20 696) (n=5940) (n=14 756)    (n=3985) (n=1155) (n=2830)   
Body mass index (kg/m2)a 24.7 (2.9) 24.5 (2.8) 24.8 (2.9) <0.001  22.1 (3.2) 22.1 (3.2) 22.1 (3.2) 0.537 
Systolic blood pressure (mmHg)a 116.0 (12.4) 114.8 (12.0) 116.5 (12.5) <0.001  103.6 (12.3) 103.1 (12.0) 103.8 (12.5) 0.097 
Diastolic blood pressure (mmHg)a 75.2 (10.3) 74.0 (9.7) 75.7 (10.3) <0.001  66.0 (9.6) 65.3 (9.4) 66.2 (9.7) 0.005 
HDL-C (mg/dL)a 51.5 (12.1) 50.2 (11.6) 52.1 (12.3) <0.001  63.4 (14.9) 62.5 (14.9) 63.8 (15.0) 0.021 
Total cholesterol (mg/dL)a 202.7 (34.5) 201.0 (34.2) 203.4 (34.6) <0.001  192.3 (33.4) 191.9 (33.4) 192.5 (33.5) 0.526 
LDL-C (mg/dL)a 129.3 (31.1) 129.9 (31.0) 129.1 (31.2) 0.115  114.0 (30.5) 114.2 (29.8) 113.9 (30.8) 0.787 
Triglycerides (mg/dL)b 123 (87–175) 118 (84–165) 125 (88–179) <0.001  75 (57–103) 75 (57–104) 74 (56–103) 0.713 
Fasting glucose (mg/dL)a 98.2 (16.1) 96.8 (14.4) 98.8 (16.8) <0.001  92.1 (12.1) 91.9 (13.9) 92.2 (11.4) 0.489 
A1C (%)a 5.66 (0.53) 5.65 (0.50) 5.67 (0.54) 0.079  5.63 (0.43) 5.63 (0.44) 5.63 (0.43) 0.984 













CAC scorec    0.044     0.184 
0 17 565 (84.9) 5097 (85.8) 12 468 (84.5)    3866 (97.0) 1129 (97.7) 2737 (96.7)   
1–100 2637 (12.7) 717 (12.1) 1920 (13.0)    109 (2.8) 23 (2.0) 86 (3.0)   
≥101 494 (2.4) 126 (2.1) 368 (2.5)    10 (0.2) 3 (0.3) 7 (0.3)   
Data are presented as ameans (standard deviation), bmedians (interquartile range), or cpercentages.  
HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; A1C, hemoglobin A1c; CAC, coronary artery calcium; HOMA-IR, 
homeostasis model assessment of insulin resistance.  
For triglycerides and HOMA-IR, Wilcoxon’s rank sum test was applied. 
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Men  Women 












Age (years)a 43.3 (9.3) 40.9 (7.0) <0.001  47.0 (9.4) 39.9 (7.5) <0.001 
Educationb          
Elementary or less 1.7  0.2  <0.001  5.6  1.7  <0.001 
Middle or high school education 12.4  11.5    31.0  25.0   
College or over 85.9  88.3    63.4  73.3   
Monthly household incomeb          
<4,000 USD 23.4  20.5  <0.001  21.5  21.1  0.001  
4,000–5,999 USD 27.3  33.2    22.5  28.0   
≥6,000 USD  29.4  33.2    30.6  31.0   
Unknown 19.9  13.1    25.4  19.9   
Cigarette smokingb         
Non-smoker  63.0  32.4  <0.001  97.9  94.1  <0.001 
Ex-smoker 17.0  32.8    1.0  3.1   
Current smoker 20.0  34.8    1.1  2.8   
Physical activityb         
Inactive 48.4  45.3  0.025  51.8  52.6  0.482 
Minimally active 41.6  47.3    41.1  39.2   
HEPA 10.0  7.4    7.1  8.2   
Adult height (cm)a 172.4 (5.9) 173.2 (5.6) <0.001  158.9 (5.4) 160.4 (5.2) 0.008 
Anti-diabetic medicationsb  2.7  3.0  0.727  3.7 1.2 <0.001 
Anti-hypertensive medicationsb 10.2  8.2  0.141  10.7 3.8 <0.001 
Anti-dyslipidemic medicationsb  5.8  4.5  0.176   5.8 2.4 <0.001 
Data are presented as ameans (standard deviation), or bpercentages.  
HEPA, health-enhancing physically active;USD, US dollars. 
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Supplementary Table 5. Unadjusted associations of lifetime drinking status with cardiovascular risk factors and coronary artery calcium 
scores. 
Variables Men  Women 
  Lifetime never-drinkers  Ever-drinkers P-value  Lifetime never-drinkers  Ever-drinkers P-value 
  (N=411) (N=20 696)    (N=738) (N=3985)   
Body mass index (kg/m2)a 24.6 (2.9) 24.7 (2.9) 0.448   22.7 (3.2) 22.1 (3.2) <0.001 
Systolic blood pressure (mmHg)a 115.0 (11.5) 116.0 (12.4) 0.084   106.9 (14.6) 103.6 (12.3) <0.001 
Diastolic blood pressure (mmHg)a 73.4 (9.3) 75.2 (10.3) <0.001  67.7 (9.8) 66.0 (9.6) <0.001 
HDL-C (mg/dL)a 50.3 (12.3) 51.5 (12.1) 0.058   59.9 (14.2) 63.4 (14.9) <0.001 
Total cholesterol (mg/dL)a 200.0 (34.2) 202.7 (34.5) 0.109   198.0 (36.9) 192.3 (33.4) <0.001 
LDL-C (mg/dL)a 129.7 (30.6) 129.3 (31.1) 0.787   122.2 (33.8) 114.0 (30.5) <0.001 
Triglycerides (mg/dL)b 116 (80–167) 123 (87–175) 0.004   84 (61–119) 75 (57–103) <0.001 
Fasting glucose (mg/dL)a 97.4 (14.0) 98.2 (16.1) 0.241   94.8 (15.4) 92.1 (12.1) <0.001 
A1C (%)a 5.70 (0.52) 5.66 (0.53) 0.143   5.76 (0.54) 5.63 (0.43) <0.001 
HOMA-IRb  1.50 (1.03–2.21) 1.47 (0.98–2.18) 0.591  1.16 (0.76–1.78) 1.11 (0.76–1.66) 0.035 
CAC scorec    0.072      <0.001 
0 80.8 84.9   90.4 97.0  
1–100 16.3 12.7   7.8 2.8  
≥101 2.9 2.4    1.8 0.2   
Data are presented as ameans (standard deviation), bmedians (interquartile range), or cpercentages.  
HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol, A1C, hemoglobin A1c; CAC, coronary artery calcium; HOMA-IR, 
homeostasis model assessment of insulin resistance.  
For triglycerides and HOMA-IR, Wilcoxon’s rank sum test was applied. 
